Drugs, dignity and drive to end AIDS

Faith-based organisations lay down AIDS roadmap at Caritas-UNAIDS meeting to strengthen collaboration and bring an end to HIV and AIDS.

In a Rome meeting organised by Caritas and UNAIDS this week, FBOs studied how to boost their work in giving life-saving care to marginalised populations in poor countries. They also looked at how to increase access to funding and resources to scale-up treatment.

“We are entering a new phase where we can see the beginning of the end of AIDS,” said Dr Luiz Loures, Assistant Secretary General of the United Nations and Deputy Executive Director of UNAIDS to the meeting’s participants.

“The faith communities have the scale, and have the means to move us forward. You care about dignity of the person – and it is only this unique combination of access to drugs and dignity that can provide the necessary drive to reach the end of AIDS.”

Caritas
Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search